1[1]Strachan D P, Carrinton D, Mendal M A, et al. Relation of chlamydia pneumoniae serology to mortality and incidence of ischemic heart disease over 13 years in the caerphilly prospective heart disease study. BMJ, 1999, 318:1035-1039.
2[2]Bartlers C, Mass M, Bein G, et al. Detection of chlamydia pneumoniae but not cytomeglovirus in occluded saphenous vein coronary artery bypass grafes. Circulation, 1999, 99:879-882.
3[3]Muhlestein J B, Hammond E H, Carlquist J F, et al. Increased incidence of chlamydia species within the coronary arteries of patient, with symptomatic atherosclerosis versus other forms of cardiovascular disease. J Am Coll Cardiol, 1996, 27:1555-1561.
4[4]Laitinen K, Laurila A, Pyhala A, et al. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun, 1997, 65:4832-4835.
5[5]Bauriedel G, Welsch U, Likungn J A, et al. Chlamydia pneumoniae in coronary plaquesn:Increased detection with acute coronary syndrome. Dtsch Med Wochenschr, 1999, 124:325-380.
6[6]Mehta J L, Saldeen T G P, Rand K. Interactive role of infection, inflammation and traditional risk factors 1 in atherosclerosis and coronary artery disease.J Am Coll Cardiol, 1998, 31:1217-1219.
7[7]Davidson M, Kuo C C, Middaugh J P, et al. Confirmed previous infection with chlamydia pneumoniae (TWAR) and it's presence in early coronary atherosclerosis. Circulation, 1998, 98:628-633.
8[8]Xu Q, Schett G, Perschinka H, et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation, 2000, 102:14-20.
9[9]Gupta S. Chronic infection in the aetiology of atherosclerosis focus on chlamydia pneumoniace. Atherosclerosis, 1999, 143:1-6.
3Patel P, Menduall MA, Garfington D, et al. Association of Helieobaterpylon and chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors[ J ]. BMJ, 1995,311 : 711 - 714.
4Melnick JL, Adam E, Debakey ME, et al. Possible role of eytomegalovirus in atherogensis[J ]. JAMA, 1990,263 : 2204 - 2211.
5Speir E, Yu Z - X, Victor J, et al. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase - 2 in coronary artery smooth muscle cells[J ]. Circ Res, 1998,83 : 210 - 216.
6Chiu B, Viira E, Tucker W, et al. Chlamydia pneumoniae cytomegalovirus, and herpes simplex vires in atherosclerosis of the carotid artey[J ]. Circule - tion, 1997,96 : 2144 - 2148.
7The Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature.Nomenclature and criteria of ischemic heart disease (special report).Circulation,1979,59:607-614
8Merja R,Marit VK,Timo P,et al.Infections,inflammation,and the risk of coronary heart disease.Circulation,2000,101:252-257
9Futterman LG,Lemberg L.Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors.Am J Crit Care,1998,7:240-243
10Dirk S,Kerstin W,Jurgen K.Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumonia pneumoniae seropositivity.Circulation,2001,103:1390-1395
